Nanosonics | NAN - Operating Profit

Stock Price
3.68
Daily Change
-0.02 -0.54%
Monthly
0%
Yearly
-19.12%
Q2 Forecast
3.63

Nanosonics reported AUD9.12M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Alcidion AUD 2.2M 1.76M Dec/2025
Ansell USD 146.5M 87.85M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Cochlear AUD 261.1M 135.55M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Fisher & Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Healius AUD -22.6M 47.5M Dec/2024
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Polynovo AUD 2.06M 1.18M Dec/2025
Pro Medicus AUD 94.82M 3.1M Dec/2025
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
ResMed USD 500.3M 37.95M Dec/2025
Somnomed AUD -4.16M 1.28M Jun/2023
Sonic Healthcare AUD 435.76M 193.66M Dec/2024